Weight Loss Medication News

This living topic explores the growing influence of weight loss medications, particularly GLP-1 receptor agonists, on obesity treatment and healthcare access. Key issues include the effectiveness of these drugs, the rising demand for both injectable and oral options, and the financial burden associated with monthly treatment costs, which can exceed $1,000. Articles examine the disparities in access to these medications, regional trends in usage, and the challenges posed by insurance coverage limitations. The topic also delves into concerns surrounding side effects, long-term efficacy, and the evolving landscape of prescription weight loss treatments.

Latest

Can weight-loss medication help people with psoriasis?

New research explores how treating psoriasis and obesity together may affect inflammation and skin health

Oct. 22, 2026 By Kristen Dalli

A clinical trial found broader changes in inflammation-related proteins and genes when Taltz and Zepbound were used together compared with Taltz alone.

Researchers studied 274 adults with moderate-to-severe plaque psoriasis and obesity or overweight accompanied by another weight-related health condition.

The findings offer new clues about the connection between skin disease, inflammation, and metabolism, but further research is needed to understand their full significance....

Read Article

2026